Ceruvia Lifesciences is founded in 2017, operates from its headquarter in 15 East Putnam Avenue Suite #413 Greenwich, CT 06830, US. The company operates in the Manufacturing, Pharmaceuticals sector.
Ceruvia Lifesciences specializes in Neurotransformational medicine development, Psychedelic medicine development, Cluster headache treatment, Hard-to-treat headache disorder treatment, OCD treatment, and offers services including Neurotransformational medicines, Psychedelic medicines, and Cluster headache treatments.